Skip to main content
Lyka Labs Ltd. logo

Lyka Labs Ltd. — Investor Relations & Filings

Ticker · LYKALABS ISIN · INE933A01014 LEI · 3358001RHQJBCTT1ER45 BSE.NS Manufacturing
Open in API
Filings indexed 1,205 across all filing types
Latest filing 2023-09-08 Regulatory Filings
Country IN India
Listing BSE.NS LYKALABS

About Lyka Labs Ltd.

https://www.lykalabs.com

Lyka Labs Ltd. specializes in the development, manufacture, and marketing of pharmaceutical formulations and active pharmaceutical ingredients (APIs). The company maintains a diverse product portfolio spanning multiple therapeutic categories, including anti-infectives, dermatologicals, cardiovascular agents, and pain management. A significant area of expertise for the organization is lyophilization technology, enabling the production of high-quality injectable formulations. The company operates advanced manufacturing facilities designed to meet international quality standards, supporting its operations in both domestic and global markets. Its core activities encompass the production of various dosage forms such as tablets, capsules, ointments, and sterile injectables, with a particular focus on specialized segments like cephalosporins and critical care medications.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document text is extremely short (463 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. Given the lack of content and the presence of a digital signature, this is likely a regulatory filing or certification-type document. According to the rules, such documents should be classified as Regulatory Filings (RNS).
2023-09-08 English
Pursuant to Regulation 39 (3) of the SEBI (LODR) Regulations 2015, the Company has received an intimation from Link Intime India Private Limited for loss of share certificates.
Regulatory Filings Classification · 95% confidence The document text is extremely short (463 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. Given the lack of content and the presence of a digital signature, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2023-09-08 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document text is extremely short (465 characters) and contains only a digital signature block with no substantive content, financial data, or report information. There is no indication of a full report, announcement, or detailed filing. Given the lack of content and the presence of a digital signature, this is likely an officer certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2023-08-24 English
Pursuant to Reg 39 (3) of the SEBI (LODR ) Regulation 2015, the Company has received an intimation from Link Intime India Private Limited pertaining to loss of share certificates.
Regulatory Filings Classification · 95% confidence The document text is extremely short (465 characters) and contains only a digital signature block with no substantive content, financial data, or report information. There is no indication of a full report, announcement, or detailed filing. Given the lack of content and the presence of a digital signature, this is likely an officer certification or attestation document. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2023-08-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document text is extremely short (467 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or detailed information. Given the lack of content and the presence of a digital signature, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2023-08-21 English
Pursuant to the Regulations 39 (3) of the SEBI (LODR) Regulations, 2015; the Company has issued duplicate share certificates.
Regulatory Filings Classification · 95% confidence The document text is extremely short (467 characters) and contains only a digital signature block with no substantive content or financial data. There is no indication of a report, announcement, or any specific filing type. Given the lack of content and the presence of a digital signature, this document is best classified as a Regulatory Filing (RNS), which serves as a fallback category for miscellaneous filings that do not fit other specific categories.
2023-08-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.